WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+2.4%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$6.81B
AUM Growth
+$684M
(+11%)
Cap. Flow
+$636M
Cap. Flow
% of AUM
9.34%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
980
New
186
Increased
207
Reduced
145
Closed
238
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$129M |
| 2 |
Gilead Sciences
GILD
|
$114M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$92.7M |
| 4 |
Amazon
AMZN
|
$77.2M |
| 5 |
Analog Devices
ADI
|
$70.5M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$74.7M |
| 2 |
Palo Alto Networks
PANW
|
$59.8M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$55.4M |
| 4 |
Alkermes
ALKS
|
$55.3M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$53.9M |
Sector Composition
| 1 | Healthcare | 37.87% |
| 2 | Technology | 30.7% |
| 3 | Financials | 9.21% |
| 4 | Industrials | 8.09% |
| 5 | Communication Services | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
iRobot
IRBT
$102M
| $9.68M | 0.14% |
171,900
+158,266
| +1,161% | +$8.92M |
|
|
LGV
202
DELISTED
Longview Acquisition Corp. II
LGV
| $9.67M | 0.14% |
984,500
+659,500
| +203% | +$6.48M |
|
|
AMRN
203
Amarin Corp
AMRN
$317M
| $9.57M | 0.13% |
+438,808
| New | +$9.57M |
|
204
Zymeworks
ZYME
$1.14B
| $9.56M | 0.13% |
1,554,082
-87,794
| -5% | -$540K |
|
205
Bausch Health
BHC
$2.72B
| $9.3M | 0.13% |
1,349,573
| – | – |
|
206
Corcept Therapeutics
CORT
$7.31B
| $9.28M | 0.13% |
+361,974
| New | +$9.28M |
|
|
HERA
207
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
| $9.15M | 0.13% |
921,381
+671,381
| +269% | +$6.66M |
|
208
Pulmonx
LUNG
$70.9M
| $9.14M | 0.13% |
548,512
+116,880
| +27% | +$1.95M |
|
209
Cirrus Logic
CRUS
$5.94B
| $9.12M | 0.13% |
+132,565
| New | +$9.12M |
|
|
GBT
210
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $9.11M | 0.13% |
133,700
-813,914
| -86% | -$55.4M |
|
|
MRNS
211
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $9.1M | 0.13% |
+1,368,123
| New | +$9.1M |
|
|
FTVI
212
DELISTED
FinTech Acquisition Corp. VI Class A Common Stock
FTVI
| $8.96M | 0.13% |
901,019
+125,000
| +16% | +$1.24M |
|
213
Toast
TOST
$24B
| $8.71M | 0.12% |
+520,643
| New | +$8.71M |
|
214
Jazz Pharmaceuticals
JAZZ
$7.86B
| $8.61M | 0.12% |
64,602
-332,259
| -84% | -$44.3M |
|
|
KLRS
215
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.4M
| $8.58M | 0.12% |
47,265
| – | – |
|
216
TJX Companies
TJX
$155B
| $8.29M | 0.12% |
133,484
+22,583
| +20% | +$1.4M |
|
217
GlobalFoundries
GFS
$18.5B
| $8.27M | 0.12% |
+171,082
| New | +$8.27M |
|
218
Karyopharm Therapeutics
KPTI
$57.2M
| $8.26M | 0.12% |
+100,884
| New | +$8.26M |
|
|
SPLK
219
DELISTED
Splunk Inc
SPLK
| $8.23M | 0.12% |
109,429
+49,950
| +84% | +$3.76M |
|
|
SNRH
220
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
| $8.15M | 0.11% |
818,975
| – | – |
|
221
Planet Fitness
PLNT
$8.77B
| $8.11M | 0.11% |
140,569
+11,380
| +9% | +$656K |
|
222
Roivant Sciences
ROIV
$8.82B
| $8.05M | 0.11% |
+2,499,335
| New | +$8.05M |
|
|
LCAA
223
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
| $8.03M | 0.11% |
810,400
+10,400
| +1% | +$103K |
|
224
Esperion Therapeutics
ESPR
$540M
| $8.01M | 0.11% |
1,195,705
+351,070
| +42% | +$2.35M |
|
225
Fox Class A
FOXA
$27.4B
| $7.94M | 0.11% |
258,717
-43,357
| -14% | -$1.33M |
|